Loading organizations...
Key people at Orfin Ventures.
Orfin Ventures operates as a single-family office, providing investment capital to promising ventures. The firm primarily focuses on early-stage technology, growth, and private-equity opportunities, leveraging resources to support innovative companies. Its approach involves deploying patient capital, blending rigorous financial assessment with long-term value creation.
Co-founded in 2011 by Adam Finkel and Gregg Orley, Orfin Ventures emerged from the Orley family's multi-generational entrepreneurial success in operating businesses and real estate since the 1950s. This history provided the insight to channel capital into new ventures, recognizing the transformative potential of early-stage opportunities through a seasoned investment lens.
Orfin Ventures primarily serves companies seeking early-stage and growth capital across technology and private equity. The firm's long-term vision centers on fostering innovation by partnering with founders developing disruptive business models. It aims to contribute to the sustained growth of its portfolio companies through strategic involvement.
Key people at Orfin Ventures.
Orfin Ventures has 3 tracked investments across 2 companies. The latest tracked deal is $14.0M Series B in Sight Machine in March 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 1, 2016 | Sight Machine | $14.0M Series B | Jump Capital | 7BC Venture Capital, Angelic Ventures, DNX Ventures, Jenny Fielding, Mercury Fund, Momenta Ventures, Refinery Ventures, Reign Ventures, Rubicon VC, Karen Kerr, Huron River Ventures, IA Ventures, O'Reilly AlphaTech Ventures, Pritzker Group Venture Capital, LOU Rassey |
| Oct 13, 2015 | Health Gorilla | $2.4M Series A | James Hardiman | Harris Barton, JON Callaghan, Venture Investment Associates |
| Feb 1, 2015 | Sight Machine | $5.0M Series A | Mercury Fund | 7BC Venture Capital, Angelic Ventures, Jenny Fielding, Jump Capital, Refinery Ventures, Reign Ventures, Rubicon VC, Elab Ventures, FundersClub, Huron River Ventures, IA Ventures, O'Reilly AlphaTech Ventures |
# Orfin Ventures: An Operator-First Venture Capital Collective
Orfin Ventures is an early to growth-stage venture capital firm headquartered in Bloomfield Hills, Michigan, operating as an investor collective focused on backing innovative, high-growth potential ventures[1]. The firm's mission centers on helping "the global economy roar back" through strategic capital deployment and hands-on operational support[1].
The fund maintains a thematic investment approach with particular emphasis on transformative opportunities across fintech, artificial intelligence, health tech, blockchain, and Web3 sectors[1]. Orfin's investment philosophy is distinctly operator-first, meaning the firm takes a hands-on approach to foster growth in portfolio companies rather than adopting a passive capital provider model[1]. The fund typically deploys capital in deal sizes ranging from $5-10 million and participates in investment rounds with 7-8 co-investors, suggesting a collaborative approach to risk distribution and syndication[2].
While specific founding details remain limited in available sources, Orfin Ventures emerged with a fund manager who brings extensive expertise in venture capital, having successfully led over 30 investments across technology, healthcare, and consumer sectors spanning North America and Europe[1]. The firm's peak activity occurred in 2016, indicating the fund was actively deploying capital during a robust period for venture investing[2]. Adam Finkel is listed as a primary contact within the organization[1].
The fund's track record includes notable exits and a demonstrated ability to deliver returns to investors, establishing credibility within the venture ecosystem[1]. This operational pedigree—rooted in deep industry knowledge and hands-on experience—forms the foundation of Orfin's investment thesis and approach to portfolio company support.
Operator-First Model: Unlike many traditional venture firms that function primarily as capital allocators, Orfin emphasizes direct operational involvement with portfolio companies[1]. This approach leverages the fund manager's three decades of investment experience to provide strategic guidance beyond capital deployment.
Thematic Investment Focus: The firm employs a deliberate thematic strategy rather than opportunistic deal-by-deal investing, allowing for deeper expertise development in high-growth sectors including AI, fintech, and health tech[1]. This specialization enables better pattern recognition and more informed conviction-building around emerging opportunities.
Syndication Strength: Orfin regularly co-invests with established partners including O'Reilly AlphaTech Ventures, Mercury Fund, and IA Ventures, indicating strong relationships within the venture community and access to deal flow networks[2]. This syndication approach reduces individual fund risk while expanding the firm's reach and influence.
Portfolio Quality: Notable portfolio companies include Augury, Sight Machine, and Health Gorilla, representing companies operating at the intersection of industrial technology, manufacturing intelligence, and healthcare innovation[2]. These investments demonstrate the fund's ability to identify companies addressing substantial market problems.
Orfin Ventures operates within a venture ecosystem increasingly focused on artificial intelligence, data infrastructure, and sector-specific software solutions. The firm's concentration in AI, machine learning, and big data reflects broader market trends toward automation, intelligent systems, and data-driven decision-making across industries[2].
The fund's emphasis on health tech and fintech positions it at the intersection of two massive market opportunities: healthcare digitization and financial services disruption. By backing companies in these domains during a period of accelerating digital transformation, Orfin captures exposure to secular tailwinds reshaping how consumers and enterprises access critical services.
The firm's operator-first philosophy also reflects a broader shift in venture capital toward value-add models. As competition for deal flow intensifies and founders increasingly demand operational support beyond capital, firms that can credibly offer hands-on guidance—particularly those staffed by former operators—gain competitive advantages in deal sourcing and portfolio company outcomes.
Orfin Ventures represents a disciplined, thematically-focused venture player with genuine operational credibility and a track record of identifying transformative companies. The firm's concentration in AI, fintech, and health tech positions it well for the next decade of technology-driven market disruption, particularly as enterprises and consumers increasingly demand intelligent, specialized solutions.
The fund's collaborative syndication approach and operator-first model suggest a maturation of venture capital toward partnership-based models that prioritize founder success over pure financial engineering. As the venture landscape becomes more crowded and capital more abundant, firms like Orfin that combine deep domain expertise with genuine operational support will likely continue attracting quality deal flow and delivering outsized returns.
The trajectory forward likely involves continued focus on early-stage companies with 2-3 years of operating history—the sweet spot where product-market fit signals are emerging but significant scaling capital remains available[2]. In an era where AI capabilities are becoming table stakes across industries, Orfin's thematic focus on artificial intelligence and machine learning positions the firm to capture value as these technologies permeate fintech, health tech, and enterprise software markets.